Home › Heart Valve Diseases › Illinois › Chicago
Heart Valve Diseases clinical trials in Chicago, IL
5 studies for Heart Valve Diseases are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Recruiting
- Northwestern Memorial Hospital, Chicago
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
The TRICURE EFS Study
Recruiting
- Northwestern, Chicago
EFS of the DUO System for Tricuspid Regurgitation
Recruiting
- Northwestern University, Chicago
Transpacific TAVR Registry
RecruitingObservational study
- Northwestern Memorial Hospital, Chicago
About Heart Valve Diseases
Heart valve disease happens when one or more of your heart valves do not open or close correctly. This can affect your blood flow and strain your heart.
More about Heart Valve Diseases on MedlinePlus
Heart Valve Diseases trials in other cities
- Cleveland, OH10 studies
- New York City, NY10 studies
- Phoenix, AZ6 studies
- Cincinnati, OH6 studies
- Los Angeles, CA5 studies
- Philadelphia, PA5 studies
- Wichita, KS5 studies
- Minneapolis, MN5 studies
- Pittsburgh, PA4 studies
- Boston, MA4 studies
- Atlanta, GA4 studies
- San Francisco, CA4 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.